British Journal of Clinical Pharmacology

Submit your papers to BJCP today!

⬆️ World leading journal
🌍 International readership
🥇 Gold-standard peer reviewing
⏱️ Fast publication
👐 Option to publish

Find out more: https://ow.ly/rIEZ50Q271o
Call for papers: https://ow.ly/NBb850Q271l

⬆️ Submit your papers to the British Journal of Clinical Pharmacology: https://ow.ly/ZlSq50Q27bW
We're a world-leading journal with an international readership and a gold-standard peer review process.
Check out our calls for papers: https://ow.ly/IeBO50Q27c0

In 2020, the European Medicines Agency (EMA) published guidelines on quality, nonclinical and clinical aspects of medicinal products containing genetically modified cells. Here is a summary of the main issues communicated in that guidance, along with the regulators' insights and a commentary from the academic developers' point of view: https://ow.ly/2CUL50SbHhN

TEPs ATMPs

Submit your papers to BJCP today!

⬆️ World leading journal
🌍 International readership
🥇 Gold-standard peer reviewing
⏱️ Fast publication
👐 Option to publish

Find out more: https://ow.ly/nctX50Q26Yr
Call for papers: https://ow.ly/AGvr50Q26Yq

BJCP paper "Effect of lipophilicity on drug distribution and elimination: Influence of obesity" (2021) by Bruno et. al cited in this HealthCentral article about the lack of clinical trials that include patients with obesity.

Obese People Are Missing in Many Clinical Trials, Increasing Their Health Risks Medications break down and behave differently in the bodies of seriously overweight people, who comprise nearly half of all American adults. Why isn’t this group being studied in major drug trials?

A fascinating afternoon at the British Journal of Pharmacology event looking at the present and future of clinical pharmacology! Thank you to everyone for joining us.

Thank you to speakers:
Prof Michael Rieder
Prof Catriona Waitt
Sammy Ainsworth
Elle Lappin
Prof Ann Daly
Prof Oscar Della Pasqua
Dr Daniel Marks
Prof Geert Jan Groeneveld
Dame June Raine
Prof Munir Pirmohamed

Thank you also to Chairs:
Prof Reecha Sofat
Dr Emma Magavern
Dr James Fullerton

Great sessions this morning, looking at the 50 year history of the BJCP and how clinical pharmacology has evolved over those years.

Thanks to speakers:
Prof Tilli Tansey
Prof Geoffrey Tucker
Dr Jeffrey Aronson
Prof James (Jim) Ritter
Prof Adam Cohen
Prof Serge Cremers
Dr Andrew Webb
Prof Robert Likic
Prof James Dear

Thanks also to Chairs:
Prof Robin Ferner
Prof Robert Flanagan
Prof Robert Bies

Lovely to see so many of you at the celebration this morning! A great welcome from BPS President Prof Sir Mark Caulfield to Queen Mary University of London.

⬆️ Submit your papers to the British Journal of Clinical Pharmacology: https://ow.ly/ZcPw50Q279I
We're a world-leading journal with an international readership and a gold-standard peer review process.
Check out our calls for papers: https://ow.ly/J67K50Q279J

Celebrate the past, present and future of at our 50th anniversary celebration event at Queen Mary University of London on 23 April 2024. Join us to hear international speakers discuss a range of topics including clinical pharmacology post-WWII, the impact of the BJCP, toxicology, global outreach, patient advocacy, personalised medicine, clinical drug development and more! Register now: https://ow.ly/HcxQ50Rf9mR

“Linked health data can generate insights into how opioids are used in the Australian community. This knowledge helps inform interventions that will improve prescribing practice and quality use of medicines.”
- Dr Malcolm Gillies, biostatistician from the Medicines Intelligence Research Program at University of New South Wales.

Read the article: https://ow.ly/6rrF50Rbe5A

Read the full paper in the British Journal of Clinical Pharmacology: https://ow.ly/YIkC50Rbe5z

Who is using oxycodone in NSW and why? A sociodemographic study of the use of oxycodone usage in NSW shows women of childbearing age, people living in regional areas and older people were more likely to have been prescribed the opioid.

Submit your papers to BJCP today!

⬆️ World leading journal
🌍 International readership
🥇 Gold-standard peer reviewing
⏱️ Fast publication
👐 Option to publish

Find out more: https://ow.ly/H0G750Q26Xw
Call for papers: https://ow.ly/ygO350Q26XC

⬆️ Submit your papers to the British Journal of Clinical Pharmacology: https://ow.ly/SkXs50Q277W
We're a world-leading journal with an international readership and a gold-standard peer review process.
Check out our calls for papers: https://ow.ly/LCsy50Q277X

We are pleased that our journals publisher, Wiley, is among the first signatories to the Joint Commitment for Action on Inclusion and Diversity in Publishing, a global network of publishers which aims to drive positive change within by collaborating on key inclusion and diversity principles. Wiley also supports The Coalition for Diversity and Inclusion in Scholarly Communications (C4DISC) Joint Statement of Principles. Find out more about this, including their Guidelines for Inclusive Language Guidelines: https://authorservices.wiley.com/author-resources/Journal-Authors/Prepare/manuscript-preparation-guidelines.html/inclusive-language-guidelines.html

The British Pharmacological Society commits to placing equity, diversity and inclusion at the heart of pharmacology. You can find out more by reading our vision for inclusive pharmacology:
https://www.bps.ac.uk/about/our-campaigns/equality,-diversity-inclusion-in-pharmacology/our-vision

Find out more about publishing in the BPS journals:
British Journal of Pharmacology: https://bpspubs.onlinelibrary.wiley.com/hub/journal/14765381/author-guidelines.html
British Journal of Clinical Pharmacology: https://bpspubs.onlinelibrary.wiley.com/hub/journal/13652125/author-guidelines.html
Pharmacology Research & Perspectives: https://bpspubs.onlinelibrary.wiley.com/hub/journal/20521707/publish-with-pharmacology-research-and-perspectives.html

Submit your papers to BJCP today!

⬆️ World leading journal
🌍 International readership
🥇 Gold-standard peer reviewing
⏱️ Fast publication
👐 Option to publish

Find out more: https://bpspubs.onlinelibrary.wiley.com/hub/journal/13652125/publish-with-british-journal-of-clinical-pharmacology.html
Call for papers: https://bpspubs.onlinelibrary.wiley.com/hub/journal/13652125/call-for-papers.html

Submit your papers to BJCP today!

⬆️ World leading journal
🌍 International readership
🥇 Gold-standard peer reviewing
⏱️ Fast publication
👐 Option to publish

Find out more: http://ow.ly/T5uZ50N3AHV
Call for papers: http://ow.ly/vhc850N3AHU

📣 on the development and use of . The carbon footprint and environmental impact of medicines we develop and use to treat disease and restore health must be a top priority for the global clinical pharmacology community. We are seeking submissions on the challenges facing clinical pharmacologists and pharmacists in reducing the environmental impact of medicines. We are also seeking submissions on solutions that are being researched and developed and may already be in practice to enable medicines to be sustainable and accessible to all who may need them. We are especially interested in international perspectives and particularly welcome original research articles, as well as reviews, commentary and short reports. We hope this series will be a springboard of ideas and grow to be an excellent resource that supports sustainable therapeutics. Find out more and submit your papers: https://ow.ly/g9WO50Q8mJe

📣 for an upcoming themed issue on Trans and Gender Diverse Populations: https://ow.ly/JqwA50Q8GlC

We invite papers that explore advances in trans care, including optimisation of gender-affirming hormone therapy ( ) and sexually transmitted and blood-borne infections ( ) preventative and treatment strategies, and future direction of the field. The deadline for submissions is Feb 1 2024.

📣 Calling all Clinical Pharmacologists! This , we want to know what or who inspired you to pursue your career and the impact of your work on and . Share your stories now in the comments or sharing this post!

🌍 In light of the PM's revised plans for reaching , we'd like to share this joint editorial from 2021 by Lukoye Atwoli
et al., which calls for emergency action to limit global temperature increases, restore biodiversity, and protect health: https://ow.ly/m4pV50POzKM

The first study to compare LDL-C lowering to a range of clinical and heart and brain MRI imaging biomarkers indicates "no evidence for adverse disease associations, except diarrhoea. However, the PCSK9-inhibitor proxy was associated with lower lung capacity, requiring further investigation".

Read now: https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.15793

Jerry He and John Parker from Toronto investigated the effect of vitamin C (ascorbic acid) on nitroglycerin-mediated vasodilation in individuals with and without the aldehyde dehydrogenase2 polymorphism: https://ow.ly/2baV50PK2Mp

"A nice example of an experimental medicine paper that helps us understand the pharmacogenetics of glyceryl trinitrate (GTN)." - Serge Cremer, Editor-in-chief for BJCP